Meeting
2021 ASCO Annual Meeting
Patient and treatment characteristics of emergency presentations due to immune-mediated toxicities.
Authors
Sharon Hyo-Eun Nahm
The Christie NHS Foundation Trust, Manchester, United Kingdom
Sharon Hyo-Eun Nahm , Richard Heywood , Sophia Callaghan , Patricio Serra-Bellver , Avinash Gupta , Tim Cooksley , Paul Lorigan
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Health Services Research and Quality Improvement
Track
Quality Care/Health Services Research
Sub Track
Real-World Data/Outcomes
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 6586)
DOI
10.1200/JCO.2021.39.15_suppl.6586
Abstract #
6586
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Annual Meeting
Toxicity associated with ipilimumab and nivolumab (Ipi+Nivo) combination therapy in melanoma patients (pts) treated at a single-institution under an expanded-access program (EAP).
First Author: Claire Frances Friedman
Poster
2022 ASCO Annual Meeting
Progression and mortality post-immunotherapy discontinuation among patients with BRAFV600-mutant (BRAF+) metastatic melanoma.
First Author: Sunandana Chandra
Poster
2019 ASCO Annual Meeting
Efficacy of immune checkpoint inhibitors (ICIs) for in-transit melanoma.
First Author: Emilia Nan Tie
Poster
2019 ASCO-SITC Clinical Immuno-Oncology Symposium
Comparison of care patterns for hospitalized immune-related adverse events (irAEs) between melanoma patients on combination immune checkpoint inhibitor (ICI) therapy versus ICI monotherapy.
First Author: RuiQui Chen